Cranial MRI Findings in Rheumatoid Arthritis Patients Treated with Rituximab: Prevalence, Patterns, and Clinical Correlates. (PubMed, J Clin Med) - Oct 17, 2026 - "No treatment-related demyelinating disease or progressive multifocal leukoencephalopathy was observed, but the study was not designed to assess drug safety, and these findings should be interpreted as the absence of an observed imaging signal rather than as evidence of the neurological safety of rituximab. Cranial neuroimaging in RA should therefore be interpreted cautiously and in clinical context."
Journal • CNS Disorders • Immunology • Inflammation • Inflammatory Arthritis • Rare Diseases • Rheumatoid Arthritis • Rheumatology
|
|
Gizem Güllü; Nihal Lermi; Selime Ermurat; Yavuz Pehlivan
|